Maryland Capital Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Maryland Capital Advisors’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48	Buy	+1	New	+$51	﹤0.01%	908

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Maryland Capital Advisors's PBH Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in Prestige Consumer Healthcare (PBH) in Q2 2026: 1 share worth $48. The stake represents ﹤0.01% of the portfolio and ranks #908 among its holdings.

318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

Maryland Capital Advisors held 1 share of Prestige Consumer Healthcare worth $48 as of Q2 2026.
Prestige Consumer Healthcare was a new Maryland Capital Advisors position in Q2 2026.
Prestige Consumer Healthcare made up ﹤0.01% of Maryland Capital Advisors's portfolio in Q2 2026, its #908 holding.
318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.